Latent tuberculosis infections in hard-to-reach drug using population – detection, prevention and control

Hwang, Lu Yu; Grimes, Carolyn Z.; Beasley, R. Palmer; Graviss, Edward A.

doi:10.1016/s1472-9792(09)70010-1

Cited by 14 publications

(9 citation statements)

References 45 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Without proper diagnosis, infected people are the major source of infection in the community [128]. It is estimated that about 3 million people remain undiagnosed or are not notified [129].…”

Section: Alzheimer's Disease and Other Forms Of Dementiamentioning

confidence: 99%

“…Due to the multitude of smart healthcare applications, only four applications in the field of diseases diagnosis, cardiovascular diseases [82][83][84][85][86][87][88][89][90][91][92][93][94][95][96][97][98][99], diabetes mellitus [100][101][102][103][104][105][106][107][108][109][110][111][112], Alzheimer's disease and other forms of dementias [113][114][115][116][117][118][119][120][121][122][123][124][125][126], and tuberculosis [127][128][129][130][13...…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Disease Diagnosis in Smart Healthcare: Innovation, Technologies and Applications

et al. 2017

View full text Add to dashboard Cite

Abstract:To promote sustainable development, the smart city implies a global vision that merges artificial intelligence, big data, decision making, information and communication technology (ICT), and the internet-of-things (IoT). The ageing issue is an aspect that researchers, companies and government should devote efforts in developing smart healthcare innovative technology and applications. In this paper, the topic of disease diagnosis in smart healthcare is reviewed. Typical emerging optimization algorithms and machine learning algorithms are summarized. Evolutionary optimization, stochastic optimization and combinatorial optimization are covered. Owning to the fact that there are plenty of applications in healthcare, four applications in the field of diseases diagnosis (which also list in the top 10 causes of global death in 2015), namely cardiovascular diseases, diabetes mellitus, Alzheimer's disease and other forms of dementia, and tuberculosis, are considered. In addition, challenges in the deployment of disease diagnosis in healthcare have been discussed.

show abstract

Section: Alzheimer's Disease and Other Forms Of Dementiamentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Disease Diagnosis in Smart Healthcare: Innovation, Technologies and Applications

et al. 2017

View full text Add to dashboard Cite

show abstract

“…23 The test has low specificity, causing false positives in patients who had a previous history of the bacilli Calmette-Guérin (BCG) vaccination or exposure to nontuberculous mycobacteria (NTM). 24,25 It has low sensitivity in some populations, causing false negatives in immunocompromised patients with HIV infection, systemic infections, and chronic renal disease; people with prior gastrointestinal surgical procedures; people who had a live vaccination within the previous 2 months; people who are malnourished; or people taking systematic immunosuppressive medications.…”

Section: Tuberculin Skin Testmentioning

confidence: 99%

Advances in Diagnosis and Treatment of Latent Tuberculosis Infection

Chapman

Lauzardo

2014

The Journal of the American Board of Family Medicine

View full text Add to dashboard Cite

“…Furthermore, the worldwide prevalence of latent TB infection (LTBI) in PWUDs (reported to be around 10–59% from various settings) is higher than that of the general population (Deiss et al, 2009). In many countries, incidence of active TB disease (estimated at 1–2 per 100 person–year) (Hwang, Grimes, Beasley, & Graviss, 2009) and TB-related mortality, particularly among PLWHA, are markedly higher than overall national rates (Deiss et al, 2009; World Health Organization (WHO), 2008). …”

Section: Introductionmentioning

confidence: 99%

Tuberculosis screening in a novel substance abuse treatment center in Malaysia: Implications for a comprehensive approach for integrated care

Al-Darraji

Wong

Yeow

et al. 2014

Journal of Substance Abuse Treatment

View full text Add to dashboard Cite

People who use drugs (PWUD) represent a key high risk group for tuberculosis (TB). The prevalence of both latent TB infection (LTBI) and active disease in drug treatment centers in Malaysia is unknown. A cross-sectional convenience survey was conducted to assess the prevalence and correlates of LTBI among attendees at a recently created voluntary drug treatment center using a standardized questionnaire and tuberculin skin testing (TST). Participants (N = 196) were mostly men (95%), under 40 (median age = 36 years) and reported heroin use immediately before treatment entry (75%). Positive TST prevalence was 86.7%. Nine (4.6%) participants were HIV-infected. Previous arrest/incarcerations (AOR = 1.1 for every entry, p < 0.05) and not being HIV-infected (AOR = 6.04, p = 0.03) were significantly associated with TST positivity. There is an urgent need to establish TB screening and treatment programs in substance abuse treatment centers and to tailor service delivery to the complex treatment needs of patients with multiple medical and psychiatric co-morbidities.

show abstract

Latent tuberculosis infections in hard-to-reach drug using population – detection, prevention and control

Cited by 14 publications

References 45 publications

Disease Diagnosis in Smart Healthcare: Innovation, Technologies and Applications

Disease Diagnosis in Smart Healthcare: Innovation, Technologies and Applications

Advances in Diagnosis and Treatment of Latent Tuberculosis Infection

Tuberculosis screening in a novel substance abuse treatment center in Malaysia: Implications for a comprehensive approach for integrated care

Contact Info

Product

Resources

About